tb-500/bpc-157 BPC-157 & TB-500 10mg Combo Pen UK BPC-157 + TB-500 Blend -

OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship

Haematological manifestations typically appear first

Bacteriostatic water is ideal for multi-dose regimens, where a medication may need to be reconstituted and used over several days or weeks

Our medical team provides thorough training for self-injection at home, or patients may choose to come in for in-office administration

Formula: CHNO